DBS in Dystonia and Other Hyperkinetic Movement Disorders.

Details

Serval ID
serval:BIB_246214FF1285
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
DBS in Dystonia and Other Hyperkinetic Movement Disorders.
Journal
Current Treatment Options in Neurology
Author(s)
Barbey A., Bloch J., Vingerhoets F.J.
ISSN
1092-8480 (Print)
ISSN-L
1092-8480
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
17
Number
9
Pages
373
Language
english
Notes
Document Type: Review
Abstract
OPINION STATEMENT: The diagnosis and appropriate treatment of hyperkinetic movement disorders require a work up of potentially reversible metabolic, infectious and structural disorders as well as side effects of current medication. In pharmacoresistant movement disorders with a disabling impact on quality of life, deep brain stimulation (DBS) should be considered. At different targets, DBS has become an established therapy for Parkinson's disease (GPi-STN), tremor (VIM) and primary dystonia (GPi) with reasonable perioperative risks and side effects, established guidelines and some clinical and radiological predictive factors. In contrast, for other hyperkinetic movement disorders, including secondary dystonia, Gilles de la Tourette, chorea and ballism, only few data are available. Definite targets are not well defined, and reported results are of less magnitude than those of the recognized indications. In this expanding therapeutical field without worked out recommendations, an individual approach is needed with DBS indication assessment only after rigorous multidisciplinary scrutiny, restricted to expert centres.
Pubmed
Web of science
Create date
05/10/2015 12:43
Last modification date
20/08/2019 13:02
Usage data